Skip to main content

NeoLight expands its horizons from jaundice to complete neonatal health

NeoLight gained traction as a Valley startup years ago with its light therapy treatment for neonatal jaundice, but the pandemic forced the company — that is now backed financially by a former NFL quarterback — to think bigger. See how buying an ocular screening company fits into NeoLight's vision of transforming neonatal care.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.